Preliminary results of a larval resistance test to ivermectins using Boophilus microplus reference strains

Sarcoptes scabiei var. canis refractory to ivermectin treatment in two dogs

A 10-year-old castrated male Shih Tzu presented with severe generalized pruritus. Skin scrapings revealed the presence of Sarcoptes scabiei var. canis. A Yorkshire terrier in the same household simultaneously developed pruritus due to scabies. Both dogs were treated with 300 μg/kg ivermectin, at first orally and then subcutaneously at 14 day intervals. However, live mites were still found on day 35, and the skin condition deteriorated in both dogs. These findings suggested that the S. scabiei in these dogs was clinically refractory to ivermectin. The pruritus in both dogs rapidly and completely disappeared following topical fipronil administration. This appears to be the first report of canine scabies refractory to ivermectin treatment.

SENSITIVITY OF BOOPHILUS MICROPLUS (ACARI: IXODIDAE) TO PYRETHROIDS AND ORGANOPHOSPHATE IN FARMS IN THE VALE DO PARAÍBA REGION, SÃO PAULO, BRAZIL

ABSTRACT A study to evaluate the resistance of B. microplus to the active principles cypermethrin, deltamethrin and chlorpyriphos was performed together with the survey of the tick control practices used in 12 farms located in Vale do Paraíba Region, São Paulo, Brazil. Results obtained by the larval packet test (LPT) technique, adopted by FAO, showed established resistance to pyrethroids (cypermethrin 16.7% sensitive, 8.3% resistant level I and 75% resistant level II; deltamethrin 25% /sensitive, 33.3% resistant level II and 41.7% resistant level III) and emerging resistance to organophosphate compounds (chlorpiriphos 58.3% sensitive, 33.3% resistant level I and 8.4% resistant level II). The inquiry applied to the farmers showed that the combination of organophosphates and pyrethroids compounds products is the most commonly tick-killing compounds used in the region, followed by amitraz and macrocyclic lactones.

Comparison of in vitro and in vivo ectoparasiticide activity of experimental benzimidazole-carbamate with permethrin and amitraz

A series of in vitro and in vivo bioassays were conducted to assess the ectoparasiticide activity of isopropyl-4-nitro-2,6-bis(trifluoromethyl)-1-benzimidazole-carbamate, an experimental benzimidazole-carbamate class compound. This compound was less potent than permethrin against ectoparasiticide-susceptible larvae of the lone star tick, Amblyomma americanum (L.) (Acari: Ixodidae); larvae of the southern cattle tick, Boophilus microplus (Canestrini); and adult stable fly, Stomoxys calcitrans (L.) (Diptera: Muscidae) in vitro, but it was significantly more potent than permethrin against the Santa Luiza strain of B. microplus known to possess high-level resistance to amitraz and pyrethroids. In contrast, the benzimidazole-carbamate was substantially more efficacious than permethrin when applied topically onto rats that were infested with A. americanum nymphs. These results suggest that this experimental compound may be a viable candidate ectoparasiticide that retains significant activity against resistant B. microplus and also suggests that the benzimidazole-carbamate chemistry may be useful for addressing the growing problem of resistance in ectoparasites.

An in vitro larval immersion microassay for identifying and characterizing candidate acaricides

We have optimized a larval immersion microassay (LIM) that offers superior sensitivity, flexibility to accommodate multiple formulations, and a robust capability for rapidly screening many compounds with a minimal requirement of test article for evaluation. Dose-response studies were conducted for representative members from the organophosphate, pyrethroid, pyrazole, carbamate, macrocyclic lactone, and formamidine chemistries against Amblyomma americanum (L.). Time-response experiments revealed that permethrin was the most rapid acting, whereas fipronil had the slowest speed-of-kill against A. americanum. Comparison of drug susceptibility profiles between multiple ixodid ticks suggests that A. americanum is an effective model for predicting compound potency against Boophilus spp. in this bioassay. The LIM is suitable for the identification and characterization of active molecules from small- and medium-sized compound or natural product libraries, and it can be a useful tool to prioritize molecules for further in vivo testing in animal models.

First documentation of in vivo and in vitro ivermectin resistance in Sarcoptes scabiei

Ivermectin is increasingly being used to treat scabies, especially crusted (Norwegian) scabies. However, treatment failures, recrudescence, and reinfection can occur, even after multiple doses. Ivermectin resistance has been documented for some intestinal helminths in animals with intensive ivermectin exposure. Ivermectin resistance has also been induced in arthropods in laboratory experiments but, to date, has not been documented among arthropods in nature. We report clinical and in vitro evidence of ivermectin resistance in 2 patients with multiple recurrences of crusted scabies who had previously received 30 and 58 doses of ivermectin over 4 and 4.5 years, respectively. As predicted, ivermectin resistance in scabies mites can develop after intensive ivermectin use.